Dec 30, 2025 03:02PM Freedom Capital Markets Starts Climb Bio (CLYM) at Buy

Dec 18, 2025 06:47AM Climb Bio (CLYM) PT Raised to $11 at H.C. Wainwright

Oct 21, 2025 07:00AM Climb Bio names Adam Villa, Ashley Jones to senior VP roles

Oct 16, 2025 06:02AM William Blair Starts Climb Bio (CLYM) at Outperform

Oct 13, 2025 06:37AM H.C. Wainwright Starts Climb Bio (CLYM) at Buy

Sep 30, 2025 07:16AM Oppenheimer on Climb Bio (CLYM): 'Positive CLYM116 Reveal Carves Path Forward in IgAN'

Sep 30, 2025 06:06AM Climb Bio (CLYM) PT Raised to $8 at BTIG

Sep 29, 2025 07:01AM Climb Bio reports preclinical data for IgAN drug candidate

Aug 15, 2025 08:59AM Baird Initiated Climb Bio (CLYM) at Outperform

Aug 12, 2025 04:24PM Climb Bio, Inc. (CLYM) Tops Q2 EPS by 5c

Jun 18, 2025 07:01AM Climb Bio (CLYM) Appoints Edgar D. Charles as Chief Medical Officer

Jun 6, 2025 06:47AM Oppenheimer Starts Climb Bio (CLYM) at Outperform,. PT $10

May 22, 2025 06:20AM BTIG Starts Climb Bio (CLYM) at Buy

May 14, 2025 05:16PM Climb Bio, Inc. (CLYM) Misses Q1 EPS by 16c

Apr 1, 2025 07:03AM Climb Bio (CLYM) Appoints Kim Cobleigh Drapkin and Bo Cumbo to its Board

Mar 25, 2025 04:41PM Climb Bio, Inc. (CLYM) Reports Q4 Loss of $0.13

Feb 24, 2025 07:04AM Climb Bio (CLYM) Appoints Perrin Wilson as Chief Business Officer

Dec 19, 2024 07:03AM Climb Bio (CLYM) to be Added to the Nasdaq Biotechnology Index

Dec 2, 2024 06:20AM Leerink Partners Starts Climb Bio (CLYM) at Outperform

Nov 15, 2024 12:59AM Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13

Oct 11, 2024 12:32PM Climb Bio (CLYM) Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

Oct 2, 2024 09:01AM Eliem Therapeutics (ELYM) Rebrands as Climb Bio (CLYM)